Conference Coverage

Experts debate venous sinus stenting for intracranial hypertension


 

EXPERT ANALYSIS AT THE SCOTTSDALE HEADACHE SYMPOSIUM

References

Patients need dual antiplatelet therapy after venous sinus stenting, and the rate of chronic patency after the procedure is unknown, Dr. Albuquerque noted. Patients can develop scalp pain over the stented segment, he added.

“I think if you limit this procedure to a very select group of patients, I think its efficacy is tremendous,” Dr. Albuquerque concluded.

Dr. Albuquerque declared no conflicts of interest. Dr. Friedman reported serving on the speakers bureau of Allergan, receiving research grants from the National Eye Institute, Merck & Co., and ElectroCore, and having served as an expert witness (for the plaintiff and defense) on idiopathic intracranial hypertension.

Pages

Recommended Reading

Repeat CT selectively in children with traumatic brain injuries
MDedge Surgery
Nerve growth factor gene therapy delivered safely in Alzheimer’s patients
MDedge Surgery
Memory fares better with laser ablation for epilepsy than with surgery
MDedge Surgery
Regionalized trauma care boosts TBI survival
MDedge Surgery
Vasodilator cocktail beats single-agent infusion for subarachnoid hemorrhage vasospasm
MDedge Surgery
Strong nerves, teamwork key in managing neurosurgical patients, devices
MDedge Surgery
Frozen or powdered? Anticoagulation options in trauma are expanding
MDedge Surgery
Vagal nerve blockade effects on morbid obesity warrant further study
MDedge Surgery
Decompression can save lives in ventricular trapping
MDedge Surgery
Palliative consult helps geriatric trauma patients avoid futile interventions
MDedge Surgery